Cargando…

The ACE2 receptor accelerates but is not biochemically required for SARS-CoV-2 membrane fusion

The SARS-CoV-2 coronavirus infects human cells via the ACE2 receptor. Structural evidence suggests that ACE2 may not just serve as an attachment factor but also conformationally activate the SARS-CoV-2 spike protein for membrane fusion. Here, we test that hypothesis directly, using DNA-lipid tetheri...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cervantes, Marcos, Hess, Tobin, Morbioli, Giorgio G., Sengar, Anjali, Kasson, Peter M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society of Chemistry 2023
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10306070/ https://www.ncbi.nlm.nih.gov/pubmed/37389252 http://dx.doi.org/10.1039/d2sc06967a

Ejemplares similares

Understanding Activation and Inhibition of SARS-CoV-2 Viral Entry with Single-Virus Microscopy
por: Sengar, Anjali, et al.
Publicado: (2021)

Single-Virus Fusion Measurements Reveal Multiple Mechanistically Equivalent Pathways for SARS-CoV-2 Entry
por: Sengar, Anjali, et al.
Publicado: (2023)

Elucidating coronavirus fusion mechanisms
por: Hess, Tobin, et al.
Publicado: (2023)

Experimental and clinical data analysis for identification of COVID-19 resistant ACE2 mutations
por: Raghav, Pawan Kumar, et al.
Publicado: (2023)

Control of Membrane Fusion Mechanism by Lipid Composition: Predictions from Ensemble Molecular Dynamics
por: Kasson, Peter M, et al.
Publicado: (2007)

Biochemical Characterization of SARS-CoV-2 Spike RBD Mutations and Their Impact on ACE2 Receptor Binding
por: Hoter, Abdullah, et al.
Publicado: (2022)

Biochemical requirements for the targeting and fusion of ER-derived transport vesicles with purified yeast Golgi membranes
Publicado: (1996)

Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells
por: Ma, Huabin, et al.
Publicado: (2021)

Extrinsic stabilization of antiviral ACE2-Fc fusion proteins targeting SARS-CoV-2
por: Svilenov, Hristo L., et al.
Publicado: (2023)

SARS-CoV-2 spike engagement of ACE2 primes S2′ site cleavage and fusion initiation
por: Yu, Shi, et al.
Publicado: (2021)

Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
por: Batlle, Daniel, et al.
Publicado: (2022)

Membrane-associated zinc peptidase families: comparing ACE and ACE2
por: Guy, J.L., et al.
Publicado: (2005)

Response to Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
por: Yeung, Man Lung, et al.
Publicado: (2022)

ACE2-binding exposes the SARS-CoV-2 fusion peptide to broadly neutralizing coronavirus antibodies
por: Low, Jun Siong, et al.
Publicado: (2022)

Novel ACE2 fusion protein with adapting activity against SARS-CoV-2 variants in vitro
por: Zekri, Latifa, et al.
Publicado: (2023)

Influenza Virus Membrane Fusion Is Promoted by the Endosome-Resident Phospholipid Bis(monoacylglycero)phosphate
por: Mannsverk, Steinar, et al.
Publicado: (2022)

Interaction of Human ACE2 to Membrane-Bound SARS-CoV-1 and SARS-CoV-2 S Glycoproteins
por: Anand, Sai Priya, et al.
Publicado: (2020)

Cell-autonomous requirement for ACE2 across organs in lethal mouse SARS-CoV-2 infection
por: Tang, Alan T., et al.
Publicado: (2023)

Rapid, reliable, and reproducible cell fusion assay to quantify SARS-Cov-2 spike interaction with hACE2
por: Zhao, Min, et al.
Publicado: (2021)

Identification of potential plant bioactive as SARS-CoV-2 Spike protein and human ACE2 fusion inhibitors
por: Singh, Rahul, et al.
Publicado: (2021)

ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV-2
por: Iwanaga, Naoki, et al.
Publicado: (2021)

An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants
por: Liu, Juan, et al.
Publicado: (2023)

SARS-CoV-2 spike protein binding selectively accelerates substrate-specific catalytic activity of ACE2
por: Kiseleva, Anna A, et al.
Publicado: (2021)

ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010)

Influenza viral membrane fusion is sensitive to sterol concentration but surprisingly robust to sterol chemical identity
por: Zawada, Katarzyna E., et al.
Publicado: (2016)

Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction
por: Biagioli, Michele, et al.
Publicado: (2021)

Comparative analysis reveals the species-specific genetic determinants of ACE2 required for SARS-CoV-2 entry
por: Ren, Wenlin, et al.
Publicado: (2021)

Effect of Et2Zn on Binding Spike Protein of SARS-Cov-2 and ACE2 from Cell Membrane
por: Maziar Noei, et al.
Publicado: (2023)

A novel biparatopic hybrid antibody-ACE2 fusion that blocks SARS-CoV-2 infection: implications for therapy
por: Miao, Xiaoniu, et al.
Publicado: (2020)

Novel ACE2-IgG1 fusions with improved in vitro and in vivo activity against SARS-CoV2
por: Iwanaga, Naoki, et al.
Publicado: (2020)

ACE2-Fc fusion protein overcomes viral escape by potently neutralizing SARS-CoV-2 variants of concern
por: Tsai, Tsung-I, et al.
Publicado: (2022)

Multimeric ACE2-IgM fusions as broadly active antivirals that potently neutralize SARS-CoV-2 variants
por: Svilenov, Hristo L., et al.
Publicado: (2022)

Early shedding of membrane-bounded ACE2 could be an indicator for disease severity in SARS-CoV-2
por: Mariappan, Vignesh, et al.
Publicado: (2022)

pH Dependence of Zika Membrane Fusion Kinetics Reveals an Off-Pathway State
por: Rawle, Robert J., et al.
Publicado: (2018)

Binding of SARS-COV-2 (COVID-19) and SARS-COV to human ACE2: Identifying binding sites and consequences on ACE2 stiffness
por: Faisal, H.M. Nasrullah, et al.
Publicado: (2021)

Acid phosphatase 2 (ACP2) is required for membrane fusion during influenza virus entry
por: Lee, Jihye, et al.
Publicado: (2017)

Soluble ACE2 in SARS-CoV-2 infection
por: Allison, Susan
Publicado: (2021)

ACE2: the molecular doorway to SARS-CoV-2
por: Medina-Enríquez, Miriam Marlene, et al.
Publicado: (2020)

Fish ACE2 is not susceptible to SARS-CoV-2
por: Xie, Shi-Zhe, et al.
Publicado: (2022)

Identification of potential inhibitors of SARS-CoV-2 S protein–ACE2 interaction by in silico drug repurposing
por: Tristán-Flores, Fabiola E, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cpvfnh7u70hko5utk4nf59pcg5